13 biotech companies to discover in the Swiss Health Valley in 2023
We recently featured BioAlps on the Beyond Biotech Podcast. While Basel is certainly a European…
January 31, 2023 - 6 minutes
Switzerland
Beyond Biotech podcast 30: Advanced Therapies Congress, BioAlps, Bionter, C2i Genomics
The guests on our podcast this week are: Jessica Robinson, project director, Advanced Therapies Congress,…
January 20, 2023 - 3 minutes
Cell and gene therapies gain momentum in Basel
Companies specializing in the research and development of innovative cell and gene therapies continue to…
January 17, 2023 - 5 minutes
Navignostics maps tumor proteomes to improve precision oncology
New cancer drugs are entering the market every year, but it’s hard to know which…
January 5, 2023 - 4 minutes
Watch: Aphaia Pharma interview
Aphaia Pharma is a Zug, Switzerland, headquartered clinical-stage biopharmaceutical company. It harnesses proprietary precision-targeted drug…
December 21, 2022 - 1 minute
Watch: Araris Biotech at Bio-Europe
Araris Biotech AG is a Swiss-headquartered company pioneering the development of its novel antibody-drug-conjugate (ADC)-linker…
December 21, 2022 - 2 minutes
PDC*line Pharma presents first immunological results from trial with PDC*lung01
PDC*line Pharma, a clinical stage biotech company has announced the first immunological results of its…
December 8, 2022 - 3 minutes
MetrioPharm reveals COVID-19 study data
MetrioPharm AG, a Swiss pharmaceutical company developing drugs for inflammatory diseases, has announced topline data…
December 8, 2022 - 4 minutes
Laevoroc Oncology pushes for relapsed leukemia cure
Laevoroc Oncology, a privately-owned, Swiss oncology development company, has announced the publication of key preclinical…
December 8, 2022 - 2 minutes
Neuraxpharm’s expansion into the Netherlands takes it from two to 20 countries in six years
Neuraxpharm Group, a European pharmaceutical company focused on the treatment of central nervous system (CNS)…
December 7, 2022 - 3 minutes
INSPIRE launched to develop inhaled gene therapy for the treatment of lung cancer
OmniSpirant Limited and EVerZom have launched INSPIRE, a €12.8 million ($13.4 million) lung cancer project…
December 6, 2022 - 3 minutes
Localizing BRCA gene mutations to better treat ovarian cancer
Mutations of BRCA1 and BRCA2 genes, which are inherited by 1 in 400 and 1…
November 28, 2022 - 5 minutes
